BRUSSELS / ATHENS, 9 October 2026 — Belgian animal-nutrition group Innovad has taken a majority stake in Greece’s Olea Fortius through a phytogenics joint venture effective 30 September 2026, according to industry publication eFeedLink. The move strengthens Innovad’s position in plant-based feed ingredients, with a focus on olive-derived by-products and their potential application in animal nutrition.
The development reflects continued commercial interest in phytogenics—plant-derived compounds and ingredients used in feed formulations to support animal health, gastrointestinal function and production performance.
Building a platform around olive-derived ingredients
The joint venture provides a route for Innovad to expand its involvement in ingredients derived from olives and related processing by-products. Depending on the specific materials and manufacturing processes involved, olive-derived ingredients may contain a range of plant compounds, including polyphenols and other bioactive constituents.
However, the nutritional and functional properties of these materials can vary considerably with olive variety, cultivation conditions, processing method, extraction technology and storage. Their commercial application therefore depends on more than botanical origin alone.
For feed manufacturers, the relevant questions include the consistency of the active compounds, their stability during feed processing and storage, compatibility with other formulation components, and the ability to demonstrate benefits under practical production conditions.
The announcement does not disclose the transaction value, detailed ownership structure, production capacity, planned investment or specific product-development timetable. These details should not be assumed until the companies provide further information.
Why phytogenics matter to animal nutrition
Phytogenics have attracted interest as nutrition companies explore feed ingredients that may support gut function, feed efficiency and animal resilience. They are used in formulations across several production systems, including poultry, swine and ruminants, although the evidence base and practical relevance differ by ingredient, species, dose and production context.
For commercial nutrition programmes, a botanical ingredient must demonstrate a reliable relationship between its composition, inclusion rate and intended biological effect. Results from one preparation cannot automatically be extrapolated to another, even when both originate from the same plant.
The key evaluation criteria include:
-
Standardisation: consistent specifications for relevant compounds and other quality parameters.
-
Efficacy: reproducible results in appropriately designed trials, ideally supported by commercial-farm data.
-
Manufacturing compatibility: stability and performance through feed processing, storage and delivery.
-
Economics: cost per tonne of feed and cost per unit of measurable production benefit.
-
Regulatory compliance: authorisation, permitted uses, labelling and claims applicable in each target market.
-
Supply-chain reliability: traceability, raw-material availability and control of contaminants or undesirable residues.
Olive-derived by-products may also be relevant to circular-economy strategies when suitable processing streams can be converted into safe, consistent feed ingredients. Their value, however, depends on the composition and quality of the material, processing costs, logistics and applicable feed regulations.
Strategic implications for the animal-health and feed industries
Innovad’s reported investment brings together an established animal-nutrition business and a company associated with olive-derived ingredients. The strategic opportunity is to connect ingredient sourcing and processing with formulation expertise, technical validation and access to feed-industry customers.
If supported by product development and reliable performance evidence, this approach could help broaden the range of differentiated plant-based ingredients available to feed formulators. It may also strengthen the commercial case for selected olive-processing by-products, provided their nutritional value and safety can be demonstrated consistently.
For feed additive manufacturers, the wider competitive lesson is that differentiation increasingly depends on the combination of ingredient quality, technical support and credible evidence—not simply on marketing a product as natural or plant-based.
For producers, the ultimate test remains practical: whether a formulation produces a repeatable, economically meaningful benefit without compromising animal health, feed quality or compliance.
What to watch next
The next meaningful indicators will be the companies’ disclosure of the joint venture’s operating structure, product portfolio, manufacturing or sourcing capabilities, and commercial priorities. Product-specific efficacy data, standardised specifications and market authorisations will be particularly important in determining the opportunity’s longer-term significance.
Bottom line
Innovad’s majority investment in Olea Fortius signals a strategic expansion into olive-derived and plant-based feed ingredients. The opportunity is credible as a platform-development move, but its eventual commercial value will depend on product consistency, evidence of efficacy, competitive economics and regulatory compliance.
Source: eFeedLink, industry reporting on the Innovad–Olea Fortius joint venture, reported 9 October 2026. The transaction is described as effective 30 September 2026. Transaction value and detailed operating terms were not available in the information reviewed.
